|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070117862A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
PT1023050E
(pt)
*
|
1997-06-27 |
2013-12-04 |
Abraxis Bioscience Llc |
Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
CA2509365C
(en)
*
|
2002-12-09 |
2012-08-07 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
KR20070114753A
(ko)
*
|
2005-02-18 |
2007-12-04 |
아브락시스 바이오사이언스 인크. |
치료제의 조합 및 투여 방식, 및 조합 요법
|
|
LT3311805T
(lt)
*
|
2005-08-31 |
2020-04-27 |
Abraxis Bioscience, Llc |
Kompozicijos, apimančios silpnai vandenyje tirpius farmacinius agentus ir priešmikrobinius agentus
|
|
EP3527202A1
(en)
*
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
US8440625B2
(en)
*
|
2006-06-26 |
2013-05-14 |
University Of British Columbia |
Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers
|
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
JP2010508277A
(ja)
*
|
2006-11-01 |
2010-03-18 |
ジョージ メイソン インテレクチュアル プロパティーズ，インコーポレイテッド オブ フェアファックス，バージニア |
癌を検出および抑制するための方法
|
|
EP3470071A1
(en)
|
2006-12-14 |
2019-04-17 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
EP2131821B1
(en)
*
|
2007-03-07 |
2018-05-09 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
US20100166869A1
(en)
*
|
2007-05-03 |
2010-07-01 |
Desai Neil P |
Methods and compositions for treating pulmonary hypertension
|
|
JP5579057B2
(ja)
*
|
2007-06-01 |
2014-08-27 |
アブラクシス バイオサイエンス， エルエルシー |
再発性癌の処置のための方法および組成物
|
|
WO2009002425A2
(en)
*
|
2007-06-22 |
2008-12-31 |
Scidose Llc |
Solubilized formulation of docetaxel without tween 80
|
|
ITMI20080284A1
(it)
*
|
2008-02-22 |
2009-08-23 |
Indena Spa |
Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
|
|
MX2010011165A
(es)
*
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
|
EP2310006A4
(en)
|
2008-07-03 |
2012-04-25 |
Mayo Foundation |
CANCER TREATMENT
|
|
EP2153821A1
(en)
*
|
2008-08-06 |
2010-02-17 |
BioAlliance Pharma |
Oral formulations of camptothecin derivatives
|
|
PL2387395T3
(pl)
*
|
2009-01-16 |
2015-03-31 |
Rigel Pharmaceuticals Inc |
Inhibitory Axl do zastosowania w terapii skojarzonej do zapobiegania, leczenia lub postępowania z nowotworem przerzutowym
|
|
WO2010105172A1
(en)
|
2009-03-13 |
2010-09-16 |
Abraxis Bioscience, Llc |
Combination therapy with thiocolchicine derivatives
|
|
PT2419732T
(pt)
|
2009-04-15 |
2019-12-24 |
Abraxis Bioscience Llc |
Composições e métodos de nanopartículas isentas de priões
|
|
EP2451459B1
(en)
*
|
2009-07-07 |
2017-11-22 |
Normoxys, Inc. |
Method of reducing multi-drug resistance using inositol tripyrophosphate
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
TWI619509B
(zh)
*
|
2010-02-23 |
2018-04-01 |
建南德克公司 |
治療先前未經治療之ⅲ期或ⅳ期卵巢癌、輸卵管癌或原發性腹膜癌之卡鉑、太平洋紫杉醇與抗-vegf抗體之組合
|
|
NZ602382A
(en)
*
|
2010-03-26 |
2014-11-28 |
Abraxis Bioscience Llc |
Methods of treatment of hepatocellular carcinoma
|
|
EP3141245A1
(en)
*
|
2010-03-29 |
2017-03-15 |
Abraxis BioScience, LLC |
Methods of treating cancer
|
|
MX2012011155A
(es)
*
|
2010-03-29 |
2012-12-05 |
Abraxis Bioscience Llc |
Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
|
|
MX347225B
(es)
|
2010-06-04 |
2017-04-19 |
Abraxis Bioscience Llc * |
Metodos de tratamiento contra el cancer pancreatico.
|
|
JP6031437B2
(ja)
|
2010-06-07 |
2016-11-24 |
アブラクシス バイオサイエンス， エルエルシー |
増殖性疾患を処置するための組み合わせ療法
|
|
US20120121510A1
(en)
*
|
2010-11-11 |
2012-05-17 |
Brem Rachel F |
Localized therapy following breast cancer surgery
|
|
US20130323265A1
(en)
*
|
2010-11-15 |
2013-12-05 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with dll4 antagonists
|
|
AU2012253571A1
(en)
|
2011-05-09 |
2014-01-09 |
Mayo Foundation For Medical Education And Research |
Cancer treatments
|
|
TW201700103A
(zh)
|
2011-11-01 |
2017-01-01 |
西建公司 |
利用胞嘧啶核苷類似物之口服配方治療癌症的方法
|
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
EP3560486A1
(en)
|
2011-12-14 |
2019-10-30 |
Abraxis BioScience, LLC |
Use of polymeric excipients for lyophilization or freezing of particles
|
|
DK2825558T3
(da)
|
2012-03-13 |
2019-07-22 |
Hoffmann La Roche |
Kombinationsterapi til behandling af ovariecancer
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US9511046B2
(en)
*
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
KR102148551B1
(ko)
*
|
2013-02-11 |
2020-08-26 |
아브락시스 바이오사이언스, 엘엘씨 |
흑색종을 치료하는 방법
|
|
EP3698784A1
(en)
|
2013-03-12 |
2020-08-26 |
Abraxis BioScience, LLC |
Methods of treating lung cancer
|
|
RU2015143490A
(ru)
|
2013-03-14 |
2017-04-26 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения рака мочевого пузыря
|
|
US10842969B2
(en)
|
2013-10-25 |
2020-11-24 |
Mercator Medsystems, Inc. |
Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
|
|
WO2015134543A1
(en)
*
|
2014-03-05 |
2015-09-11 |
Sorrento Therapeutics, Inc. |
Pharmacokinetically equivalent nanoparticle compositions
|
|
EP2924022A1
(en)
*
|
2014-03-27 |
2015-09-30 |
INDENA S.p.A. |
Amorphous form of a thiocolchicine derivative
|
|
EP3154586B1
(en)
|
2014-06-13 |
2020-05-27 |
Mayo Foundation for Medical Education and Research |
Treating lymphomas
|
|
KR20170020371A
(ko)
|
2014-06-16 |
2017-02-22 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
골수종의 치료
|
|
WO2015195634A1
(en)
|
2014-06-17 |
2015-12-23 |
Celgne Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
|
WO2015018380A2
(en)
*
|
2014-07-03 |
2015-02-12 |
Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. |
Therapeutic nanoparticles and the preparation methods thereof
|
|
US9446148B2
(en)
|
2014-10-06 |
2016-09-20 |
Mayo Foundation For Medical Education And Research |
Carrier-antibody compositions and methods of making and using the same
|
|
CR20170031A
(es)
*
|
2014-10-06 |
2017-05-22 |
Mayo Found For Medical Educaction And Res |
Composiciones de portador-anticuerpo y métodos para realizarlas y utilizarlas
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
ES3009356T3
(en)
|
2015-06-29 |
2025-03-26 |
Abraxis Bioscience Llc |
Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors
|
|
WO2017176265A1
(en)
*
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
JP6921802B2
(ja)
*
|
2015-08-18 |
2021-08-18 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ |
キャリア結合剤組成物およびそれを作製および使用する方法
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105288639A
(zh)
*
|
2015-11-23 |
2016-02-03 |
中国药科大学 |
一种载阿霉素的主动靶向白蛋白纳米载体的制备及其应用
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
WO2017139698A1
(en)
*
|
2016-02-12 |
2017-08-17 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
EP3432926A4
(en)
*
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
METHOD FOR REDUCING THE TOXICITY OF CHEMOTHERAPEUTICS
|
|
EP3432928A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
CN109922836A
(zh)
*
|
2016-08-05 |
2019-06-21 |
梅奥医学教育和研究基金会 |
用于癌症治疗的经修饰抗体-白蛋白纳米颗粒复合物
|
|
TWI771315B
(zh)
*
|
2016-08-26 |
2022-07-21 |
奧野哲治 |
微小奈米化藥劑及其利用
|
|
JP2019526579A
(ja)
|
2016-09-01 |
2019-09-19 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ |
Ｔ細胞癌を標的とする為の方法及び組成物
|
|
WO2018045239A1
(en)
|
2016-09-01 |
2018-03-08 |
Mayo Foundation For Medical Education And Research |
Carrier-pd-l1 binding agent compositions for treating cancers
|
|
RU2021128415A
(ru)
|
2016-09-06 |
2021-11-08 |
Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч |
Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения
|
|
EP3509635A1
(en)
|
2016-09-06 |
2019-07-17 |
Vavotar Life Sciences LLC |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
KR20230011473A
(ko)
|
2016-09-06 |
2023-01-20 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
Ｐｄ－ｌ１ 발현 암의 치료 방법
|
|
CN106310291A
(zh)
*
|
2016-09-14 |
2017-01-11 |
东南大学 |
主动靶向抗肿瘤纳米药物及其制备方法和应用
|
|
AU2017347853B2
(en)
|
2016-10-27 |
2022-02-17 |
Celgene Quanticel Research, Inc. |
Bromodomain and extra-terminal protein inhibitor combination therapy
|
|
CA3042238C
(en)
*
|
2016-10-28 |
2021-08-10 |
Nant Holdings Ip, Llc |
Avatar dendritic cells: the neoantigen natural killer t-cell chemo immuno radiation composition inducing immunogenic cell death
|
|
EP3706750A1
(en)
|
2017-11-06 |
2020-09-16 |
RAPT Therapeutics, Inc. |
Chemokine receptor modulators for treatment of epstein barr virus positive cancer
|
|
WO2019104042A1
(en)
*
|
2017-11-21 |
2019-05-31 |
University Of Iowa Research Foundation |
Synthetically lethal nanoparticles for treatment of cancers
|
|
EP3727368A4
(en)
*
|
2017-12-19 |
2021-10-20 |
Abraxis BioScience, LLC |
METHOD OF TREATMENT IN COLON CANCER WITH NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
|
|
AU2019212622B2
(en)
|
2018-01-26 |
2024-05-23 |
The Regents Of The University Of California |
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
|
|
IL277402B1
(en)
|
2018-03-20 |
2026-04-01 |
Abraxis Bioscience Llc |
Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin
|
|
BR112022007710A2
(pt)
|
2019-10-28 |
2022-07-12 |
Abraxis Bioscience Llc |
Composições farmacêuticas de albumina e rapamicina
|
|
BR112022010113A2
(pt)
|
2019-11-25 |
2022-09-06 |
Univ California |
Inibidores de vegf de longa ação para neovascularização intraocular
|
|
KR102263606B1
(ko)
|
2020-02-11 |
2021-06-10 |
충북대학교 산학협력단 |
파클리탁셀과 알피늄이소플라본을 함유한 나노 마이셀, 이의 제조방법 및 이의 용도
|